MedShare

Advanced Search

The prevalence of EGFR mutations and ALK rearrangements in lung adenocarcinoma, and the frequency of concomitant mutations

The prevalence of EGFR mutations and ALK rearrangements in lung adenocarcinoma, and the frequency of concomitant mutations

Research Project Report (2015-2016)

Author: Ms Katharina Lutz
Supervisor: Prof Dr med Irina Berger, Dr med Andreas Nagel
Group: Pathology
Keywords: adenocarcinoma, nsclc, concomitant egfr and alk alterations, anaplastic lymphoma kinase (alk), epidermal growth factor receptor (egfr)

Toolbox